Absence of detectable monkeypox virus DNA in 11,000 English blood donations during the 2022 outbreak
Transfusion · 2023
DOI: 10.1111/trf.17266 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transfusion, 2023. Verfasst von Chanice Knight und 9 weiteren Autor:innen. Beteiligte Einrichtung: Nuffield Department of Medicine, Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, UK. Hauptthemen laut MEDLINE: Mpox, Monkeypox, Sexual and Gender Minorities. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Department of Health.
Abstract (Originalsprache)
Background
A large, worldwide outbreak of mpox (formerly referred to as monkeypox) involving mainly men who have sex with men commenced in May 2022. We evaluated the frequency of positivity for the causative agent, monkeypox virus (MPXV), in blood donations collected in August 2022, during the outbreak period in Southern England. Methods/Materials The sensitivity and specificity of an MPXV‐specific PCR and a generic non‐variola orthopoxvirus (NVO) PCR were evaluated using samples from mpox cases and synthetic DNA standards. Residual minipools from nucleic acid testing were obtained from 10,896 blood donors in Southern England, with 21% from London.
Results
MPXV and NVO PCRs were both capable of detection of single copies of target sequence with calculated limits of detection (LOD) 90 s of 2.3 and 2.1 DNA copies and analytical sample sensitivities of 46 and 42 MPXV DNA copies/ml, respectively. 454 minipools produced from 10,896 unique donors were assayed for MPXV DNA by both methods. No positive minipools were detected by either PCR.
Conclusions
Although blood donors are unrepresentative of the UK population in terms of MPXV infection risk, the uniformly negative MPXV DNA testing results provide reassurance that MPXV viraemia and potential transmission risk were rare or absent in donors during the outbreak period. Minipools from blood donors allow rapid implementation of large‐scale population‐based screening for emerging pathogens and represent an important resource for pandemic preparedness.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Nuffield Department of Medicine, Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, UK.
- Centre Hospitalier Universitaire (CHU) Grenoble-Alpes, Grenoble, France.
- NHSBT Filton Testing/Blood Supply, Bristol, UK.
- Sydney Infectious Diseases Institute, Faculty of Medicine and Health, University of Sydney, Sydney, Australia.
- Big Data Institute, Nuffield Department of Medicine, Oxford, UK.
- Division of Infection and Immunity, University College London, London, UK.
ORCID-Profile: Heli Harvala, Peter Simmonds
Förderung
- Department of Health
Zitieren
APA
Knight, C., Andreani, J., Garrett, N., Winter, M., Golubchik, T., Breuer, J., Reynolds, C., Brailsford, S. R., Harvala, H., & Simmonds, P. (2023). Absence of detectable monkeypox virus DNA in 11,000 English blood donations during the 2022 outbreak. Transfusion. https://doi.org/10.1111/trf.17266
Vancouver
Knight C, Andreani J, Garrett N, Winter M, Golubchik T, Breuer J, et al. Absence of detectable monkeypox virus DNA in 11,000 English blood donations during the 2022 outbreak. Transfusion. 2023. doi:10.1111/trf.17266
BibTeX
@article{Knight2023,
author = {Knight, Chanice and Andreani, Julien and Garrett, Neil and Winter, Mark and Golubchik, Tanya and Breuer, Judy and Reynolds, Claire and Brailsford, Susan R and Harvala, Heli and Simmonds, Peter},
title = {Absence of detectable monkeypox virus DNA in 11,000 English blood donations during the 2022 outbreak},
journal = {Transfusion},
year = {2023},
doi = {10.1111/trf.17266}
}
EUVIMED